Literature DB >> 18599493

Promoter polymorphism of interleukin-18 in angiographically proven coronary artery disease.

Wenwei Liu1, Qizhu Tang, Hua Jiang, Xiangwu Ding, Yongsheng Liu, Rui Zhu, Yongqian Tang, Bin Li, Min Wei.   

Abstract

Interleukin 18 (IL-18) is a pro-atherogenic cytokine associated with the occurrence of various cardiac complications. The IL-18 gene has a functional -137 G/C polymorphism (rs187238) in the promoter region. Using the ligase detection reaction-polymerase chain reaction, we genotyped a cohort of patients in Chinese Han population in Xiangfan region. Case patients of coronary artery disease and control patients were identified by coronary angiography. The plasma IL-18 concentrations were measured by ELISA. A significant increase of G allele or GG-genotype was observed in 241 case patients compared to 145 control individuals (frequency of G allele = 0.90 vs 0.83, p=0.004; frequency of GG-genotype = 0.81 vs 0.68, p = 0.005). In case patients, G allele carriers in multi-vessel disease patients had a higher occurrence rate when compared to single-vessel disease patients, but no significant difference was detected (frequency of G allele = 0.92 vs 0.88, p=0.107; frequency of GG-genotype = 0.84 vs 0.75, p = 0.089). IL-18 protein concentration of the -137GG genotype was much higher than concentration of the CG and CC genotype (case patients: 229.1+/-131.5 vs 122.7+/-73.6 pg/ml, P < 0.001; control patients: 65.9+/-31.6 vs 42.4+/-19.5 pg/ml, P < 0.001). To conclude, IL-18 promoter -137G/C polymorphism influences IL-18 levels and the occurrence of coronary artery disease, suggesting that IL-18 is causally involved in the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599493     DOI: 10.1177/0003319708319939

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  16 in total

1.  Increased IL18 mRNA levels in peripheral artery disease and its association with triglyceride and LDL cholesterol levels: a pilot study.

Authors:  Serkan Burc Deser; Burcu Bayoglu; Kazım Besirli; Mujgan Cengiz; Berk Arapi; Yerik Junusbekov; Ahmet Dirican; Caner Arslan
Journal:  Heart Vessels       Date:  2015-10-05       Impact factor: 2.037

2.  The frequency of an IL-18-associated haplotype in Africans.

Authors:  Simon R Thompson; Steve E Humphries; Mark G Thomas; Rosemary Ekong; Ayele Tarekegn; Endeshaw Bekele; Olivia Creemer; Neil Bradman; Krishna R Veeramah
Journal:  Eur J Hum Genet       Date:  2012-08-29       Impact factor: 4.246

3.  Plasma levels of interleukin 18, interleukin 10, and matrix metalloproteinase-9 and -137G/C polymorphism of interleukin 18 are associated with incidence of in-stent restenosis after percutaneous coronary intervention.

Authors:  Wenwei Liu; Yongsheng Liu; Hua Jiang; Xiangwu Ding; Rui Zhu; Bin Li; Yuqin Zhao
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

4.  Evaluation of the Role of -137G/C Single Nucleotide Polymorphism (rs187238) and Gene Expression Levels of the IL-18 in Patients with Coronary Artery Disease.

Authors:  Fatemeh Hoseini; Sanaz Mahmazi; Khalil Mahmoodi; Gholam Ali Jafari; Mohammad Soleiman Soltanpour
Journal:  Oman Med J       Date:  2018-03

Review 5.  Interleukin 18 and coronary heart disease: prospective study and systematic review.

Authors:  Barbara J M H Jefferis; Olia Papacosta; Christopher G Owen; S Goya Wannamethee; Steve E Humphries; Mark Woodward; Lucy T Lennon; Andrew Thomson; Paul Welsh; Ann Rumley; Gordon D O Lowe; Peter H Whincup
Journal:  Atherosclerosis       Date:  2011-03-24       Impact factor: 5.162

6.  IL-18 inhibits growth of murine orthotopic prostate carcinomas via both adaptive and innate immune mechanisms.

Authors:  Brian Wan-Chi Tse; Pamela Joan Russell; Matthias Lochner; Irmgard Förster; Carl Andrew Power
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

7.  Interleukin-18 Promoter Gene Polymorphisms are not Associated with Myocardial Infarction in Type 2 Diabetes in Slovenia.

Authors:  S Kariž; D Petrovič
Journal:  Balkan J Med Genet       Date:  2011-06       Impact factor: 0.519

8.  Investigation on the IL-18 -607A/C and -137C/G on the susceptibility of ischemic stroke.

Authors:  Jin-He Shi; Li-Dan Niu; Xi-Yan Chen; Jing-Yu Hou; Ping Yang; Guang-Peng Li
Journal:  Pak J Med Sci       Date:  2015 Jan-Feb       Impact factor: 1.088

9.  Correlation between interleukin-18 promoter -607C/A polymorphism and susceptibility to ischemic stroke.

Authors:  Jian-xia Lu; Zhong-qian Lu; Shao-lan Zhang; Juan Zhi; Zheng-ping Chen; Wan-xiang Wang
Journal:  Braz J Med Biol Res       Date:  2013-05-24       Impact factor: 2.590

10.  Ischemic stroke susceptibility gene in a Northern Han Chinese population.

Authors:  Haiping Wang; Shujuan Shi; Wenjing Yan; Yan Song; Jingjing Zhan; Chen Zhang; Haiji Wang
Journal:  Neural Regen Res       Date:  2013-07-15       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.